Pliura D H, Bonaventura B J, Smith R A, Coles P J, Krantz A
Syntex Research, Mississauga, Ontario, Canada.
Biochem J. 1992 Dec 15;288 ( Pt 3)(Pt 3):759-62. doi: 10.1042/bj2880759.
Peptidyl acyloxymethyl ketones, previously established as potent inactivators of the lysosomal cysteine proteinase cathepsin B, were evaluated against smooth-muscle calpain, a member of the family of Ca(2+)-dependent cysteine proteinases. Only modest rates of time-dependent inhibition could be achieved, even with peptidyl affinity groups optimized for calpain and linked to a carboxylate leaving group of very low pKa [2,6-(CF3)2PhCOO-, pKa 0.58]. Selective inactivation of cathespin B versus calpain was consistently observed with this type of inhibitor. Examination of other potential inhibitors revealed a rank order of potency against calpain to be: peptidyl sulphonium methyl ketones > fluoromethyl ketones, diazomethyl ketones >> acyloxymethyl ketones, an order which differs sharply from that found for cathespin B.
肽基酰氧基甲基酮类化合物先前已被确认为溶酶体半胱氨酸蛋白酶组织蛋白酶B的有效失活剂,本研究对其针对平滑肌钙蛋白酶(一种依赖Ca(2+)的半胱氨酸蛋白酶家族成员)进行了评估。即使使用针对钙蛋白酶优化并与极低pKa的羧酸根离去基团[2,6-(CF3)2PhCOO-,pKa 0.58]相连的肽基亲和基团,也只能实现适度的时间依赖性抑制率。使用这类抑制剂时,始终观察到组织蛋白酶B相对于钙蛋白酶的选择性失活。对其他潜在抑制剂的研究表明,它们对钙蛋白酶的效力排序为:肽基锍甲基酮>氟甲基酮、重氮甲基酮>>酰氧基甲基酮,这一顺序与组织蛋白酶B的情况截然不同。